This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paola Bollini, MD, MPH; Luis A. García Rodríguez, MD, MSc; Susanne Pérez Gutthann, MD, MPH; Alexander M. Walker, MD, DrPH

Arch Intern Med. 1992;152(6):1289-1295.

Abstract
Background.—
Considerable differences in the estimates of the risk of upper gastrointestinal tract disease associated with treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) have been observed. We conducted a meta-analysis of epidemiologic studies of upper gastrointestinal tract disease related to NSAIDs to answer the following research questions: Are study characteristics (study design and quality) associated with different estimates of risk, for both aspirin and nonaspirin NSAIDs? Does the risk increase for particular groups of patients, such as women and the elderly?

Methods.—
Thirty-four studies addressing severe upper gastrointestinal tract disease associated with NSAIDs (including aspirin and nonaspirin NSAIDs) were examined and scored according to a quality checklist that we designed for this review.

Results.—
Only 44% of the studies controlled for major confounding variables (age and sex). While exposure was. defined as current in 40% and 78% of the studies for nonaspirin NSAIDs and aspirin, respectively, few investigations checked for history of ulcer disease and concurrent diseases or other comedications known to be risk factors for upper gastrointestinal tract bleeding. The overall risk ratio, by means of a random-effects regression model, was 3.0 (95% confidence interval, 1.9 to 4.7). The individual estimates for aspirin and nonaspirin NSAIDs were similar. Both with and without control for quality, cohort studies provided a lower risk ratio estimate than did case-control studies.

Conclusions.—
The design and quality of the studies appear to be strong independent predictors of the risk estimate; cohort studies were associated with lower risk estimates than case-control studies, and satisfactory studies were associated with lower risk estimates than unsatisfactory studies.

(Arch Intern Med. 1992;152:1289-1295).

Author Affiliations
From the Departments of Population Sciences (Dr Bollini) and Epidemiology (Dr Walker), Harvard University School of Public Health, Boston, Mass (Dr Bollini); and Pharmacoepidemiology Unit, CIBA-GEIGY AG, Basel, Switzerland (Drs García Rodriguez and Pérez Gutthann).

Footnotes
Accepted for publication November 16, 1991.

Reprint requests to Pharmacoepidemiology Unit, CIBA-GEIGY AG, K-490.1.51, 4002 Basel, Switzerland (Dr García Rodríguez)..

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography
Sanderson et al.
Int J Epidemiol 2007;36:666-676.
ABSTRACT | FULL TEXT  

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
Zochling et al.
Ann Rheum Dis 2006;65:423-432.
ABSTRACT | FULL TEXT  

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Zhang et al.
Ann Rheum Dis 2005;64:669-681.
ABSTRACT | FULL TEXT  

Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach
Richy et al.
Ann Rheum Dis 2004;63:759-766.
ABSTRACT | FULL TEXT  

Quality Indicators for the Management of Osteoarthritis in Vulnerable Elders
MacLean
ANN INTERN MED 2001;135:711-721.
FULL TEXT  

Association Between Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Tract Bleeding/Perforation: An Overview of Epidemiologic Studies Published in the 1990s
Hernandez-Diaz and Rodriguez
Arch Intern Med 2000;160:2093-2099.
ABSTRACT | FULL TEXT  

Risk of Hospitalization for Upper Gastrointestinal Tract Bleeding Associated With Ketorolac, Other Nonsteroidal Anti-inflammatory Drugs, Calcium Antagonists, and Other Antihypertensive Drugs
Garcia Rodriguez et al.
Arch Intern Med 1998;158:33-39.
ABSTRACT | FULL TEXT  

Value of Epidemiologic Studies in Determining the True Incidence of Adverse Events: The Nonsteroidal Anti-inflammatory Drug Story
Miwa et al.
Arch Intern Med 1997;157:2129-2136.
ABSTRACT  

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
Henry et al.
BMJ 1996;312:1563-1566.
ABSTRACT | FULL TEXT  

Use of nonsteroidal anti-inflammatory drugs in cancer
Pace
Palliat Med 1995;9:273-286.
ABSTRACT  

Peptic Ulcer and Gastrointestinal Hemorrhage Associated With Nonsteroidal Anti-inflammatory Drug Use in Patients Younger Than 65 Years: A Large Health Maintenance Organization Cohort Study
Lanza et al.
Arch Intern Med 1995;155:1371-1377.
ABSTRACT  

Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study
Evans et al.
BMJ 1995;311:22-26.
ABSTRACT | FULL TEXT  

Non-steroidal anti-inflammatory drugs and elderly patients
Bateman and Kennedy
BMJ 1995;310:817-818.
FULL TEXT